Clinical trial
A Master Protocol for Phase 2, Randomized, Controlled Studies of Multiple Interventions for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
NCT07483073 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Master Protocol for Phase 2, Randomized, Controlled Studies of Multiple Interventions for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- May 4, 2026
- Completion date
- March 31, 2028
- Enrollment
- 60 (estimated)
- Sites
- 70
Conditions
As the registry lists them; a condition with its own page is linked.